JPMorganChase leaders are asking policymakers to support CHOICE Arrangements, the newer public name for ICHRA, through legislation, tax incentives and individual-market support. This is a corporate policy position. An employer should evaluate its available coverage and current obligations using the rules and programs that actually apply today. source
What is JPMorganChase proposing?
In an undated essay, Morgan Health CEO Dan Mendelson and JPMC Business Banking CEO Stevie Baron propose three CHOICE-related measures: federal statutory codification, consideration of employer tax credits, and stronger state reinsurance programs. The essay also discusses other small-business coverage models and acknowledges that CHOICE will not fit every local market. source
Axios covered the policy position on October 29, 2026. source That dates the news coverage; the primary essay does not display a verified publication date.
The distinction matters when reading a benefits headline. A proposal can influence a future policy debate without creating a current credit, changing an employer's notice obligations or putting a new insurance policy on an employee's enrollment screen.
The three proposals address different decisions
Our analysis is that the proposals should be evaluated separately, because they address different sources of uncertainty.
| Proposal | What a business should ask |
|---|---|
| Statutory codification: writing the framework into federal statute | What legislation would change, when would it apply, and which current requirements would remain? |
| Employer tax incentives | Who qualifies, which spending counts, how is the benefit claimed, and what happens when it ends? |
| State reinsurance support | Which individual-market plans and geography are affected, and how would that appear in an actual employee quote? |
The essay describes reinsurance as state support for a portion of insurers' high-cost claims risk. Its intended effect is on the underlying insurance market, rather than a payment made directly to each participating employer. source
For example, a temporary credit and a recurring insurance premium belong on different lines of a forecast. An employer could model its contribution and administration costs both while an incentive is available and after it expires. That exercise does not require assuming that the incentive will be renewed or that the employee's premium will stay unchanged.
Likewise, a policy intended to support individual-market premiums cannot settle whether a specific plan covers an employee's doctors or medications. Keep the benefit's financing, insurance price and access to care visible as separate questions.
What can employers evaluate now?
Current federal guidance already describes an individual-coverage reimbursement arrangement, its employee-class restrictions and its interaction with Marketplace tax credits. source A future legislative proposal should not replace that existing evaluation.
Give advisers one defined workforce and request a comparison using actual locations, coverage needs, contribution assumptions and complete service charges. Separate the allowance ceiling from expected reimbursements and identify any funds required before coverage starts. Compare the resulting employer and employee responsibilities with a current group-plan option.
Our ICHRA versus group comparison and total-cost guide provide a starting structure. A state-specific incentive deserves its own eligibility review; our Connecticut credit reporting illustrates why announcements and application terms must be read together.
Read the institution's role clearly
JPMorganChase presents the essay as its policy position on small-business coverage. Its business and health-care interests are relevant context; the position is not an independent evaluation of employee outcomes. The associated Morgan Health educational hub explicitly states that Morgan Health and JPMorganChase are not a broker or adviser. source source
An educational resource can help a business prepare better questions. It does not replace a current proposal from the parties that would actually enroll employees, administer reimbursements or provide insurance. Identify those parties and their responsibilities before treating a broad institutional endorsement as a recommendation for your company.
A payment change does not identify every coverage outcome
The essay also draws on bank research. A separate JPMorganChase Institute study published April 10, 2025 follows health-insurance premium payments in business deposit-account data during 2018–2023. Its discussion acknowledges that stopping observed direct premium payments can accompany a switch to individual-market financing or a professional employer organization. source
That measurement boundary is important: a changed payment channel alone cannot tell us whether employees became uninsured, received an ICHRA or kept equivalent coverage through another arrangement. Those outcomes require additional records. For related distinctions, see our ICHRA adoption measurement analysis.
What would demonstrate that a policy worked?
Our suggested follow-up is to examine what happens after implementation, not just how many businesses express interest. A useful evaluation would distinguish first-time benefit offers from group-plan conversions and record eligible workers, enrolled workers, contribution amounts, employee premium responsibility and service costs for a defined period.
It should also examine continued participation after any incentive expires, coverage interruptions, access to needed care and changes in employee financial exposure. Missing information should remain missing rather than becoming an assumed saving. The existing employer-interest survey describes an earlier decision stage; the renewal review describes questions to answer once a benefit is operating.
For a business choosing coverage now, start with the 2027 planning outlook and evaluation brief. Document the rules, plan options and commercial terms available to you, while following the policy proposals as a separate development.
Sources and evidence
Review dates are recorded for each source above. Company pages are useful for confirming how a product is described, but they do not prove service quality or customer results.